Bio-Techne Corporation (TECH)

Healthcare · Biotechnology · NASDAQ

S&P 500

Bio-Techne Corporation (TECH) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $11.26B, a trailing price-to-earnings ratio of 37.3 and a free-cash-flow yield of 2.2%. Over the most recent reported fiscal year, revenue grew 5.2% and free cash flow per share grew 9.4%.

Market cap	$11.26B
Trailing P/E	37.3
FCF yield	2.2%
Revenue growth (YoY)	+5.2%
EPS growth (YoY)	+8.4%
FCF/share growth (YoY)	+9.4%
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live TECH data on Nama Insights →

Recent Congressional trades

Bio-Techne Corporation trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
April McClain Delaney	House	Buy	$1,001 - $15,000	Jan 1, 2026
April McClain Delaney	House	Buy	$1,001 - $15,000	May 1, 2025
Rob Bresnahan	House	Sell	$1,001 - $15,000	Apr 8, 2025
Rob Bresnahan	House	Buy	$1,001 - $15,000	Feb 25, 2025
Thomas R Tillis	Senate	Sell	$1,001 - $15,000	—